These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 32040955

  • 1. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
    Stein RM, Kang HJ, McCorvy JD, Glatfelter GC, Jones AJ, Che T, Slocum S, Huang XP, Savych O, Moroz YS, Stauch B, Johansson LC, Cherezov V, Kenakin T, Irwin JJ, Shoichet BK, Roth BL, Dubocovich ML.
    Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The endogenous melatonin (MT) signal facilitates reentrainment of the circadian system to light-induced phase advances by acting upon MT2 receptors.
    Pfeffer M, Rauch A, Korf HW, von Gall C.
    Chronobiol Int; 2012 May; 29(4):415-29. PubMed ID: 22489607
    [Abstract] [Full Text] [Related]

  • 4. Structure-based discovery of potent and selective melatonin receptor agonists.
    Patel N, Huang XP, Grandner JM, Johansson LC, Stauch B, McCorvy JD, Liu Y, Roth B, Katritch V.
    Elife; 2020 Mar 02; 9():. PubMed ID: 32118583
    [Abstract] [Full Text] [Related]

  • 5. Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle.
    López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S.
    Int J Mol Sci; 2019 May 17; 20(10):. PubMed ID: 31108968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.
    Jarzynka MJ, Passey DK, Johnson DA, Konduru NV, Fitz NF, Radio NM, Rasenick M, Benloucif S, Melan MA, Witt-Enderby PA.
    J Pineal Res; 2009 Mar 17; 46(2):161-71. PubMed ID: 19175856
    [Abstract] [Full Text] [Related]

  • 9. Docking studies for melatonin receptors.
    Alkozi HA, Sánchez Montero JM, Doadrio AL, Pintor J.
    Expert Opin Drug Discov; 2018 Mar 17; 13(3):241-248. PubMed ID: 29271261
    [Abstract] [Full Text] [Related]

  • 10. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V, Mailliet F, Lahaye-Brasseur C, Bonnaud A, Le Gall A, Amossé C, Dromaint S, Rodriguez M, Nagel N, Galizzi JP, Malpaux B, Guillaumet G, Lesieur D, Lefoulon F, Renard P, Delagrange P, Boutin JA.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun 17; 367(6):553-61. PubMed ID: 12764576
    [Abstract] [Full Text] [Related]

  • 11. Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives.
    Comai S, Lopez-Canul M, De Gregorio D, Posner A, Ettaoussi M, Guarnieri FC, Gobbi G.
    Pharmacol Res; 2019 Jun 17; 144():343-356. PubMed ID: 31029764
    [Abstract] [Full Text] [Related]

  • 12. Methods to Assess Melatonin Receptor-Mediated Phase-Shift and Re-entrainment of Rhythmic Behaviors in Mouse Models.
    Glatfelter GC, Sosa J, Hudson RL, Dubocovich ML.
    Methods Mol Biol; 2022 Jun 17; 2550():391-411. PubMed ID: 36180708
    [Abstract] [Full Text] [Related]

  • 13. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
    Wu YH, Ursinus J, Zhou JN, Scheer FA, Ai-Min B, Jockers R, van Heerikhuize J, Swaab DF.
    J Affect Disord; 2013 Jun 17; 148(2-3):357-67. PubMed ID: 23357659
    [Abstract] [Full Text] [Related]

  • 14. Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.
    Comai S, Ochoa-Sanchez R, Gobbi G.
    Behav Brain Res; 2013 Apr 15; 243():231-8. PubMed ID: 23333399
    [Abstract] [Full Text] [Related]

  • 15. Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey.
    Bedini A, Boutin JA, Legros C, Zlotos DP, Spadoni G.
    J Pineal Res; 2024 May 15; 76(4):e12953. PubMed ID: 38682544
    [Abstract] [Full Text] [Related]

  • 16. Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views.
    Comai S, Gobbi G.
    J Pineal Res; 2024 Oct 15; 76(7):e13011. PubMed ID: 39400423
    [Abstract] [Full Text] [Related]

  • 17. [Melatonin receptor agonist].
    Uchiyama M.
    Nihon Rinsho; 2015 Jun 15; 73(6):1017-22. PubMed ID: 26065135
    [Abstract] [Full Text] [Related]

  • 18. Structural basis of ligand recognition at the human MT1 melatonin receptor.
    Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V.
    Nature; 2019 May 15; 569(7755):284-288. PubMed ID: 31019306
    [Abstract] [Full Text] [Related]

  • 19. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose.
    Mühlbauer E, Gross E, Labucay K, Wolgast S, Peschke E.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):61-71. PubMed ID: 19374844
    [Abstract] [Full Text] [Related]

  • 20. In silico drug discovery of melatonin receptor ligands with therapeutic potential.
    Elisi GM, Scalvini L, Lodola A, Bedini A, Spadoni G, Rivara S.
    Expert Opin Drug Discov; 2022 Apr 15; 17(4):343-354. PubMed ID: 35255751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.